Local Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor May Provide a New Therapeutic Potential for the Treatment of Intractable Upper Airway Inflammation

Journal of Japan Society of Immunology & Allergology in Otolaryngology
doi 10.5648/jjiao.34.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society of Immunology and Allergology in Otolaryngology

Related search

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2017English

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Therapeutic Potential of Epidermal Growth Factor Receptor-Related Protein

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Inhibition of Chronic and Acute Skin Inflammation by Treatment With a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

American Journal of Pathology
Forensic MedicinePathology
2008English

Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Bone Metastases: Different Mechanisms of Action for a Novel Therapeutic Application?

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Lung Cancer Cells Survive Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Exposure Through Upregulation of Cholesterol Synthesis

FASEB BioAdvances
2019English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy